Carotid intima-media thickness in coronary slow flow: Relationship with plasma homocysteine levels

Coronary Artery Disease

Volumn 17, Issue 4, 2006, Pages 331-337

  Tanriverdi, Halil ^a,b   Evrengul, Harun ^a   Tanriverdi, Seyhan ^a   Kuru, Omur ^a   Seleci, Deniz ^a   Enli, Yasar ^a   Kaftan, Asuman ^a   Kilic, Mustafa ^a  

^a PAMUKKALE UNIVERSITY   (Turkey)

^b PAMUKKALE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Carotid atherosclerosis; Coronary slow flow; Homocysteine; Intima media thickness

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE;

ADULT; AMINO ACID BLOOD LEVEL; AMINO ACID METABOLISM; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ARTERY INTIMA PROLIFERATION; ARTERY WALL; ARTICLE; BLOOD CLOT LYSIS; BLOOD SAMPLING; BRAIN ANGIOGRAPHY; BRAIN ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CAROTID ARTERY DISEASE; CAROTID ATHEROSCLEROSIS; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORRELATION ANALYSIS; DISEASE MARKER; FEMALE; FLOWMETER; FOLIC ACID BLOOD LEVEL; HEART INFARCTION; HUMAN; MALE; NEUROPATHOLOGY; POPULATION RESEARCH; PRIORITY JOURNAL; RISK ASSESSMENT; TUNICA MEDIA; VITAMIN BLOOD LEVEL;

AGED; CAROTID ARTERIES; CAROTID ARTERY DISEASES; CASE-CONTROL STUDIES; CORONARY ANGIOGRAPHY; CORONARY ARTERIOSCLEROSIS; CORONARY CIRCULATION; FEMALE; FOLIC ACID; HOMOCYSTEINE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; REFERENCE VALUES; TUNICA INTIMA; TUNICA MEDIA;

EID: 33748139293     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019501-200606000-00002     Document Type: Article

References (41)

1. Chambless LE, Heiss G, Folsom AR, Rosamond W, Szklo M, Sharrett AR, et al. Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: The Atherosclerosis Risk In Communities (ARIC) Study. Am J Epidemiol 1997; 146:483-494.
2. Geroulakos G, O'Gorman DJ, Kalodiki E, Sheridan DJ, Nicolaides AN. The carotid intima-media thickness as a marker of the presence of severe symptomatic coronary artery disease. Eur Heart J 1994; 15:781-785.
3. Tambe AA, Demany MA, Zimmerman HA, Masearanhas E. Angina pectoris and slow flow velocity of dye in coronary arteries, a new angiographic finding. Am Heart J 1972; 84:66-71.
4. Sezgin AT, Sigirci A, Barutcu I, Topal E, Sezgin N, Ozdemir R, et al. Vascular endothelial function in patients with slow coronary flow. Coron Artery Dis 2003; 14:155-161.
5. Erbay AR, Turhan H, Yasar AS, Bicer A, Senen K, Sasmaz H, et al. Elevated level of plasma homocysteine in patients with slow coronary flow. Int J Cardiol 2005; 102:419-423.
6. Barutcu I, Sezgin AT, Sezgin N, Gullu H, Esen AM, Topal E, et al. Elevated plasma homocysteine level in slow coronary flow. Int J Cardiol 2005; 101:143-145.
7. James TN. Small arteries of the heart. Circulation 1977; 56:2-14.
8. Ratcliffe HL, Redfield E. Atherosclerotic stenosis of the extramural and intramural coronary arteries of man. Related lesions. Virchows Arch A Pathol Pathol Anat 1972; 357:1-10.
9. Nissen SE, Gurley JC, Grines CL, Booth DC, McClure R, Berk M, et al. Intravascular ultrasound assessment of lumen size and wall morphology in normal subjects and patients with coronary artery disease. Circulation 1991; 84:1087-1099.
10. Tuzcu EM, Kapadia SR, Tutar E, Ziada KM, Hobbs RE, McCarthy PM, et al. High prevalence of coronary atherosclerosis in asymptomatic teenagers and young adults: evidence from intravascular ultrasound. Circulation 2001; 103:2705-2710.
11. Malinow MR, Nieto FJ, Szklo M, Chambless LE, Bond G. Carotid artery intimal-medial wall thickening and plasma homocyst(e)ine in asymptomatic adults. The atherosclerosis risk in communities study. Circulation 1993; 87:1107-1113.
12. Gibson CM, Cannon CP, Daley WL, Dodge JT Jr, Alexander B Jr, Marble SJ. TIMI frame count: a quantitative method of assessing coronary artery flow. Circulation 1996; 93:879-888.
13. Touboul PJ, Elbaz A, Koller C, Lucas C, Adrai V, Chedru F, et al. Common carotid artery intima-media thickness and brain infarction: The Etude du Profil Genetique de l'Infarctus Cerebral (GENIC) Case-Control Study. The GENIC Investigators. Circulation 2000; 102:313.
14. Kurtoglu N, Akcay A, Dindar I. Usefulness of oral dipyridamole therapy for angiographic slow coronary artery flow. Am J Cardiol 2001; 87:777-779.
15. Camsari A, Pekdemir H, Cicek D, Polat G, Akkus MN, Doven O, et al. Endothelin-1 and nitric oxide concentrations and their response to exercise in patients with slow coronary flow. Circ J 2003; 67:1022-1028.
16. Pekdemir H, Cin VG, Cicek D, Camsari A, Akkus N, Doven O, et al. Slow coronary flow may be a sign of diffuse atherosclerosis. Contribution of FFR and IVUS. Acta Cardiol 2004; 59:127-133.
17. Stary HC, Chandler B, Glagov S, Guyton JR, Insull W Jr, Rosenfeld ME, et al. A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the committee on vascular lesions of the council on arteriosclerosis, American Heart Association. Arterioscler Thromb 1994; 14:840-856.
18. Nakatani S, Yamagishi M, Tamai J, Goto Y, Umeno T, Kawaguchi A, et al. Assessment of coronary artery distensibility by intravascular ultrasound application of simultaneous measurements of luminal area and pressure. Circulation 1995; 91:2904-2910.
19. Chilian WM, Layne SM, Klausher EC, Eastham CL, Marcus ML. Redistribution of coronary microvascular resistance produced by dipyridamole. Am J Physiol 1989; 256:383-390.
20. Zeiher AM, Schachinger V, Hohnloser SH, Saurbier B, Just H. Coronary atherosclerotic wall thickening and vascular reactivity in humans: elevated high-density lipoprotein levels ameliorate abnormal vasoconstriction in early atherosclerosis. Circulation 1994; 89:2525-2532.
21. Graham IM, Daly LE, Refsum HM, Robinson K, Brattstrom LE, Ueland PM, et al. Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. JAMA 1997; 277:1775-1781.
22. Dalery K, Lussier-Cacan S, Selhub J, Davignon J, Latour Y, Genest J Jr. Homocysteine and coronary artery disease in French Canadian subjects: relation with vitamins B12, pyridoxal phosphate, and folate. Am J Cardiol 1995; 75:1107-1111.
23. Verhoef P, Kok FJ, Kruyssen DA, Schouten EG, Witteman JC, Grobbee DE, et al. Plasma total homocysteine, B vitamins, and risk of coronary atherosclerosis. Arterioscler Thromb Vasc Biol 1997; 17:989-995.
24. Keleman LE, Anand SS, Hegele RA, Stampfer MJ, Rosner B, Willet WC, et al. Associations of plasma homocysteine and the methylenetetrahydrofolate reductase C677T polymorphism with carotid intima media thickness among South Asian, Chinese and European Canadians. Atherosclerosis 2004; 176:361-370.
25. Ridker PM, Manson JE, Buring JE, Shih J, Matias M, Hennekens CH. Homocysteine and risk of cardiovascular disease among postmenopausal women. JAMA 1999; 281:1817-1821.
26. Arnesen E, Refsum H, Bonaa KH, Ueland PM, Forde OH, Nordrehaug JE. Plasma total homocysteine and coronary heart disease. Int J Epidemiol 1995; 24:704-709.
27. Nygard O, Nordrehaug JE, Refsum H, Ueland PM, Farstad M, Vollset SE. Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med 1997; 337:230-236.
28. Bostom AG, Silbershatz H, Rosenberg IH, Selhub J, D'Agostino RB, Wolf PA, et al. Nonfasting plasma total homocysteine levels and all cause and cardiovascular disease mortality in elderly Framingham men and women. Arch Int Med 1999; 159:1077-1080.
29. Bots ML, Launer LJ, Lindemans J, Hofman A, Grobbee DE. Homocysteine and short-term risk of myocardial infarction and stroke in the elderly: The Rotterdam Study. Arch Int Med 1999; 159:38-44.
30. Ubbink JB, Fehily AM, Pickering J, Elwood PC, Vermaak WJ. Homocysteine and ischemic heart disease in the Caerphilly cohort. Atherosclerosis 1998; 140:349-356.
31. Stehouwer CD, Weijenberg MP, van den Berg M, Jakobs C, Feskens EJ, Kromhout D. Plasma homocysteine and risk of coronary heart disease and cerebrovascular disease in elderly men: a 10-year follow-up. Arterioscler Thromb Vasc Biol 1998; 18:1895-1901.
32. Durga J, Verhoef P, Bots ML, Schouten EG. Homocysteine and carotid intima-media thickness: a critical appraisal of the evidence. Atherosclerosis 2004; 176:1-19.
33. Loscalzo J. The oxidant stress of hyperhomocyst(e)inemia. J Clin Invest 1996; 98:5-7.
34. Bostom AG, Lathrop L. Hyperhomocysteinemia in end stage renal disease: prevalence, etiology and potential relationship to arteriosclerotic outcomes. Kidney Int 1997; 52:10-20.
35. Glagov S, Weisenberg E, Zarins CK, Stankunavicius R, Kolettis GJ. Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med 1987; 316:1371-1375.
36. Grobbee DE, Bots ML. Carotid artery intima-media thickness as an indicator of generalized atherosclerosis. J Intern Med 1994; 236:567-573.
37. Ebrahim S, Papacosta O, Whincup P, Wannamethee G, Walker M, Nicolaides AN, et al. Carotid plaque, intima media thickness, cardiovascular risk factors, and prevalent cardiovascular disease in men and women: The British Regional Heart Study. Stroke 1999; 30:841-850.
38. Bonithon-Kopp C, Touboul PJ, Berr C, Loroux C, Mainard F, Courbon D, Ducimetiere P. Relation of intima-media thickness to atherosclerotic plaques in carotid arteries: The Vascular Aging (EVA) Study. Arterioscler Thromb Vasc Biol 1996; 16:310-316.
39. Leskinen Y, Lehtimäki T, Loimaala A, Huhtala H, Salenius JP, Oja SS, et al. Homocysteine and carotid atherosclerosis in chronic renal failure: the confounding effect of renal function. Atherosclerosis 2004; 175:315-323.
40. McQuillan BM, Beilby JP, Nidorf M, Thompson PL, Hung J. Hyperhomocysteinemia but not the C677T mutation of methylenetetrahydrofolate reductase is an independent risk determinant of carotid wall thickening. The Perth Carotid Ultrasound Disease Assessment Study (CUDAS). Circulation 1999; 19:2383-2388.
41. Durga J, Bots ML, Schouten EG, Kok FJ, Verhoef P. Low concentrations of folate, not hyperhomocysteinemia, are associated with carotid intima-media thickness. Atherosclerosis 2005; 179:285-292.